Sanofi weighs an Insmed takeover, the FDA slams J&J over misleading bladder cancer drug claims, and more pharma news: ...
Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of ...
Infectious disease physician and STAT “ID Consult” columnist Krutika Kuppalli offers Congress a must-do list on measles.
Did the biotech company Erasca find a more potent, better-tolerated pan-RAS cancer drug than Revolution Medicines?
A monoclonal antibody holds promise in preventing malaria, but researchers found it interfered with a new vaccine when used ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The acting director of the National Institute of Allergy and ...
Two telehealth giants rolled out peptide programs this week after HHS made it easier for compounding pharmacies to offer ...
Sen. Bernie Sanders pushed back on assumptions that Trump would veto an expanded Medicare plan. “I am not absolutely certain ...
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...
As I listened to the results of the STREAM trial — which found that older adults without a history of heart attacks or ...
The National Academies urged the scientific community to respond more aggressively to claims of errors or manipulated data in ...
Merck is entering a research collaboration with Isomorphic Labs, the AI drug designer built on a Nobel-winning technology ...